Merck
  • Home
  • Search Results
  • Clinical assessment of a CMC/PEO gel to inhibit postoperative epidural adhesion formation after lumbar discectomy: a randomized, control study.

Clinical assessment of a CMC/PEO gel to inhibit postoperative epidural adhesion formation after lumbar discectomy: a randomized, control study.

Archives of orthopaedic and trauma surgery (2013-01-01)
Zhi-chen Liu, Yang Li, Yuan Zang, Geng Cui, Hong-xun Sang, Zhen-sheng Ma, Liang Kong, Wei Lei, Zi-xiang Wu
ABSTRACT

To evaluate effectiveness of carboxymethylcellulose/polyethylene oxide (CMC/PEO) gel in improving clinical outcomes after the first-time lumbar discectomy. Ninety-three patients with herniated lumbar disc at L4-L5 or L5-S1 were enrolled and randomized into two groups: CMC/PEO gel treatment group and control group. All the patients underwent laminotomy and discectomy by posterior approach. The preoperative and postoperative Oswestry Disability Index (ODI) and Visual Analogue Scale (VAS) scores for lower-back pain and leg pain were analyzed and compared between two groups at 30- and 60-day time points. No patient presented with any clinically measurable adverse event during surgery. There were no significant differences between the treated group and the control group on the preoperative ODI and VAS scores. In general, the ODI and VAS scores decreased in both groups at all the time points. At the 30-day time point, the VAS scores for back pain and leg pain and the ODI scores in treatment group were lower by 9.9 % (P = 0.0302), 27.0 % (P = 0.0002) and 16.3 % (P = 0.0007) than those in control group. And at the 60-day time point, the ODI and VAS scores further decreased in both groups. The VAS scores for leg pain in treatment group were lower by 4.5 % than that in the control group (P = 0.0149). However, no significant difference was detected between two groups on the ODI and VAS scores for back pain. The results demonstrated that CMC/PEO gel is effective in reducing posterior dural adhesions in the spine with no apparent safety issues. It can improve patients' postoperative clinical outcome.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
羧甲基纤维素钠, average Mw ~90,000
Sigma-Aldrich
羧甲基纤维素 钠盐, low viscosity
Sigma-Aldrich
羧甲基纤维素 钠盐, Medium viscosity
Sigma-Aldrich
羧甲基纤维素 钠盐, High viscosity
Sigma-Aldrich
羧甲基纤维素钠, average Mw ~700,000
Sigma-Aldrich
羧甲纤维素 钠, meets USP testing specifications, Medium viscosity
Sigma-Aldrich
羧甲基纤维素钠, average Mw ~250,000, degree of substitution 0.7
Sigma-Aldrich
羧甲基纤维素钠, average Mw ~250,000, degree of substitution 1.2
Sigma-Aldrich
羧甲基纤维素钠, average Mw ~250,000, degree of substitution 0.9
Sigma-Aldrich
羧甲基纤维素 钠盐, medium viscosity
Sigma-Aldrich
羧甲基纤维素 钠盐, ultra high viscosity, highly purified